These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
377 related articles for article (PubMed ID: 9308559)
1. Immunohistochemical nuclear staining for p53, PCNA, and Ki-67 in different histologic variants of basal cell carcinoma. Barrett TL; Smith KJ; Hodge JJ; Butler R; Hall FW; Skelton HG J Am Acad Dermatol; 1997 Sep; 37(3 Pt 1):430-7. PubMed ID: 9308559 [TBL] [Abstract][Full Text] [Related]
2. Immunohistochemical nuclear staining for p53, PCNA, Ki-67 and bcl-2 in different histologic variants of basal cell carcinoma. Mateoiu C; Pirici A; Bogdan F Rom J Morphol Embryol; 2011; 52(1 Suppl):315-9. PubMed ID: 21424069 [TBL] [Abstract][Full Text] [Related]
3. Immunohistochemical evaluation of basal cell carcinoma and trichepithelioma using Bcl-2, Ki67, PCNA and P53. Abdelsayed RA; Guijarro-Rojas M; Ibrahim NA; Sangueza OP J Cutan Pathol; 2000 Apr; 27(4):169-75. PubMed ID: 10774937 [TBL] [Abstract][Full Text] [Related]
4. Immunohistochemical staining for Ber-EP4, p53, proliferating cell nuclear antigen, Ki-67, bcl-2, CD34, and factor XIIIa in nevus sebaceus. Barrett TL; Smith KJ; Williams J; Corner SW; Hodge JJ; Skelton HG Mod Pathol; 1999 May; 12(5):450-5. PubMed ID: 10349981 [TBL] [Abstract][Full Text] [Related]
5. Expression of p16 Protein in Cutaneous Basal Cell Carcinoma: Still far from Being Clearly Understood. Bartoš V Acta Dermatovenerol Croat; 2020 Jul; 28(1):43-44. PubMed ID: 32650852 [TBL] [Abstract][Full Text] [Related]
6. Microcystic adnexal carcinoma: an immunohistochemical study including markers of proliferation and apoptosis. Smith KJ; Williams J; Corbett D; Skelton H Am J Surg Pathol; 2001 Apr; 25(4):464-71. PubMed ID: 11257620 [TBL] [Abstract][Full Text] [Related]
7. Lamin expression in normal human skin, actinic keratosis, squamous cell carcinoma and basal cell carcinoma. Tilli CM; Ramaekers FC; Broers JL; Hutchison CJ; Neumann HA Br J Dermatol; 2003 Jan; 148(1):102-9. PubMed ID: 12534602 [TBL] [Abstract][Full Text] [Related]
8. Immunohistochemical prognostic criteria in xeroderma pigmentosum. Karakok M; Turkmen A; Bekerecioglu M; Koçer NE Int J Dermatol; 2010 Nov; 49(11):1266-71. PubMed ID: 21038547 [TBL] [Abstract][Full Text] [Related]
9. Comparison of PTCH1, COX-2, p53, and Ki-67 protein expression in basal cell carcinomas of nodular and superficial subtypes arising on the head and trunk. Khalesi M; Waterhouse M; Whiteman DC; Johns R; Rosendahl C; Hackett T; Pollak T; Kimlin MG; Hacker E; Neale RE; Int J Dermatol; 2016 Oct; 55(10):1096-105. PubMed ID: 27126210 [TBL] [Abstract][Full Text] [Related]
10. Metastatic basal cell carcinoma: four case reports, review of literature, and immunohistochemical evaluation. Ionescu DN; Arida M; Jukic DM Arch Pathol Lab Med; 2006 Jan; 130(1):45-51. PubMed ID: 16390237 [TBL] [Abstract][Full Text] [Related]
11. Superficial radiotherapy for patients with basal cell carcinoma: recurrence rates, histologic subtypes, and expression of p53 and Bcl-2. Zagrodnik B; Kempf W; Seifert B; Müller B; Burg G; Urosevic M; Dummer R Cancer; 2003 Dec; 98(12):2708-14. PubMed ID: 14669293 [TBL] [Abstract][Full Text] [Related]
13. Expression of p53 in aggressive and non-aggressive histologic variants of basal cell carcinoma. Ansarin H; Daliri M; Soltani-Arabshahi R Eur J Dermatol; 2006; 16(5):543-7. PubMed ID: 17101476 [TBL] [Abstract][Full Text] [Related]
14. Expression of topoisomerase IIalpha, Ki-67, proliferating cell nuclear antigen, p53, and argyrophilic nucleolar organizer regions in vulvar squamous lesions. Brustmann H; Naudé S Gynecol Oncol; 2002 Aug; 86(2):192-9. PubMed ID: 12144828 [TBL] [Abstract][Full Text] [Related]
15. Open study of the efficacy and mechanism of action of topical imiquimod in basal cell carcinoma. Vidal D; Matías-Guiu X; Alomar A Clin Exp Dermatol; 2004 Sep; 29(5):518-25. PubMed ID: 15347339 [TBL] [Abstract][Full Text] [Related]
16. Immunohistochemical and molecular analysis of p53, MDM2, proliferating cell nuclear antigen and Ki67 in benign and malignant peripheral nerve sheath tumours. Kindblom LG; Ahldén M; Meis-Kindblom JM; Stenman G Virchows Arch; 1995; 427(1):19-26. PubMed ID: 7551341 [TBL] [Abstract][Full Text] [Related]
17. Evaluation of p53 and Ki67 Expression Profiles in Basal Cell Carcinomas in a Usual and an Unusual Location. Süngü N; Kiran MM; Tatli Doğan H; Kiliçarslan A; Karakök E; Akyol M Turk Patoloji Derg; 2018; 34(2):165-170. PubMed ID: 29630084 [TBL] [Abstract][Full Text] [Related]
18. Expression of p53, D2-40 and α-smooth muscle actin in different histological subtypes of facial basal cell carcinoma. Mercut R; Ciurea ME; Mărgăritescu C; Popescu SM; Crăitoiu MM; Cotoi OS; Voinescu DC Rom J Morphol Embryol; 2014; 55(2):263-72. PubMed ID: 24969973 [TBL] [Abstract][Full Text] [Related]
19. [Immunomorphological features of cutaneous basal-cell carcinoma]. Chuprov IN Vopr Onkol; 2008; 54(6):715-9. PubMed ID: 19241845 [TBL] [Abstract][Full Text] [Related]
20. Biologic behavior of and p53 overexpression in multifocal renal cell carcinoma of clear cell type: an immunohistochemical study correlating grading, staging, and proliferation markers. Haitel A; Wiener HG; Blaschitz U; Marberger M; Susani M Cancer; 1999 Apr; 85(7):1593-8. PubMed ID: 10193951 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]